1. Home
  2. SWKH vs CVRX Comparison

SWKH vs CVRX Comparison

Compare SWKH & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$17.16

Market Cap

205.9M

Sector

Finance

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$7.68

Market Cap

221.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWKH
CVRX
Founded
1996
2000
Country
United States
United States
Employees
9
N/A
Industry
Diversified Financial Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.9M
221.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
SWKH
CVRX
Price
$17.16
$7.68
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$18.00
$13.17
AVG Volume (30 Days)
10.3K
159.4K
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
N/A
EPS
1.85
N/A
Revenue
$40,149,000.00
$55,969,000.00
Revenue This Year
$52.93
$11.49
Revenue Next Year
N/A
$16.26
P/E Ratio
$9.19
N/A
Revenue Growth
62.38
18.44
52 Week Low
$13.17
$4.30
52 Week High
$20.49
$18.55

Technical Indicators

Market Signals
Indicator
SWKH
CVRX
Relative Strength Index (RSI) 54.00 31.55
Support Level $17.00 $7.14
Resistance Level $17.45 $8.44
Average True Range (ATR) 0.28 0.54
MACD -0.05 -0.09
Stochastic Oscillator 58.94 22.59

Price Performance

Historical Comparison
SWKH
CVRX

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: